AbbVie upgraded to Buy at Erste Group on Friday
As previously reported, Erste Group upgraded AbbVie (ABBV) to Buy from Hold. The firm notes AbbVie recently confirmed its ...
Hosted on MSN1mon
AbbVie Surges 5% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate
AbbVie stock jumped 4.7% to close at 183.90. Shares have spent the better part of this month trapped below their 200-day line, according to MarketSurge. Across all products, AbbVie generated $15.1 ...
CNN1y
AbbVie, Inc.
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune ...
GlobalData on MSN20d
CHMP recommends AbbVie’s Rinvoq be approved for adult GCA
The treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, rheumatoid arthritis and Crohn's disease, but its use for GCA is still pending ...